Cancer Drugs News
Most Popular Cancer Drugs Story
UPDATED: Pfizer nabs FDA nod for another targeted cancer drug
The FDA has stamped an approval on Pfizer's ($PFE) new kidney cancer drug axitinib, which the drug giant plans to market as Inlyta. And the approval marks another win on the targeted cancer drug Read more...
Latest Headlines
- January 27, 2012
- January 13, 2012
- January 13, 2012
- January 6, 2012
- December 29, 2011
- December 16, 2011
- November 1, 2011
- September 27, 2011
- August 26, 2011
- August 16, 2011
- June 16, 2011
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
